On July 1, ADVI Health’s director of policy, research, and analysis, Tara Southwell, sat down with Pink Sheet to discuss the provision expanding the orphan drug exemption included in the budget reconciliation bill.

In the article, “Orphan Drug Relief Still In Budget Bill But Uncertainty Remains,” Tara discusses that Congress may be interested in developing a larger healthcare package that could include PBM and other reforms not included in the budget reconciliation bill.

Read Tara’s full insights in Pink Sheet.